CompletedNot Applicable

Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy

Denmark795 participantsStarted 2022-10-01

Plain-language summary

The goal of this quasi randomized multicenter controlled clinical trial (RCT) is to investigate whether a combined real time computer-aided polyp detection (CADe) and computer-aided polyp characterization (CADx) system (GI Genius, Medtronic) can increase the adenoma detection rate (ADR) and reduce the performance variability among endoscopists. Participants will be randomized (1:1) to either receive an AI-assisted colonoscopy (AIC) or a conventional colonoscopy (CC). If there is a comparison group: Researchers will compare the AIC-group and the CC-group to see if AIC can increase the ADR significantly.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Referred for screening colonoscopy due to a positive faecal immunochemical test (FIT) or for * Diagnostic colonoscopy due to symptoms/signs or * Post-polypectomy surveillance colonoscopy (only patients who had all detected polyps removed in the previous colonoscopy) Exclusion Criteria: * Referral for removal of previous detected polyps * Emergency colonoscopy * Control colonoscopy due to inflammatory bowel disease (IBD)

What they're measuring

Adenoma detection rate (ADR)

Timeframe: 5 Months

Trial details

NCT IDNCT05740137

SponsorIsmail Gögenur

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-03

View on ClinicalTrials.gov More Colorectal Cancer trials